Lexicon Accounts Payable from 2010 to 2025

LXRX Stock  USD 0.66  0.04  5.71%   
Lexicon Pharmaceuticals Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to about 13.3 M in 2025. Accounts Payable is the amount Lexicon Pharmaceuticals owes to suppliers or vendors for products or services received but not yet paid for. It represents Lexicon Pharmaceuticals' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2000-03-31
Previous Quarter
12.2 M
Current Value
14.2 M
Quarterly Volatility
13.7 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Lexicon Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lexicon Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 473.7 K, Interest Expense of 15.8 M or Total Revenue of 1 M, as well as many indicators such as Price To Sales Ratio of 209, Dividend Yield of 0.0 or PTB Ratio of 5.52. Lexicon financial statements analysis is a perfect complement when working with Lexicon Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Lexicon Pharmaceuticals Correlation against competitors.
For more information on how to buy Lexicon Stock please use our How to Invest in Lexicon Pharmaceuticals guide.

Latest Lexicon Pharmaceuticals' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Lexicon Pharmaceuticals over the last few years. An accounting item on the balance sheet that represents Lexicon Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Lexicon Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Lexicon Pharmaceuticals' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lexicon Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Very volatile
   Accounts Payable   
       Timeline  

Lexicon Accounts Payable Regression Statistics

Arithmetic Mean16,693,409
Geometric Mean11,847,642
Coefficient Of Variation94.77
Mean Deviation10,154,921
Median13,064,000
Standard Deviation15,820,059
Sample Variance250.3T
Range56.5M
R-Value0.06
Mean Square Error267.2T
R-Squared0
Significance0.82
Slope201,590
Total Sum of Squares3754.1T

Lexicon Accounts Payable History

202513.3 M
202416.5 M
202314.4 M
202210.4 M
20219.2 M
20205.5 M
201912.2 M

About Lexicon Pharmaceuticals Financial Statements

Lexicon Pharmaceuticals investors use historical fundamental indicators, such as Lexicon Pharmaceuticals' Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lexicon Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable16.5 M13.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lexicon Stock Analysis

When running Lexicon Pharmaceuticals' price analysis, check to measure Lexicon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexicon Pharmaceuticals is operating at the current time. Most of Lexicon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lexicon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexicon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lexicon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.